FDX1 and cancer: The study illustrates that in ccRCC, reduced FDX1 expression is associated with disease progression, poor prognosis and dysregulated immune cell infiltration which illustrates that the cuproptosis related gene may serve as a potential prognostic predictor for ccRCC patients and may provide new insights into cancer treatment (129, 130).